Skip to Content

Vira Shield 6 + L5HB (Canada)

This page contains information on Vira Shield 6 + L5HB for veterinary use.
The information provided typically includes the following:
  • Vira Shield 6 + L5HB Indications
  • Warnings and cautions for Vira Shield 6 + L5HB
  • Direction and dosage information for Vira Shield 6 + L5HB

Vira Shield 6 + L5HB

This treatment applies to the following species:
Manufacturer: Novartis

Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Vaccine

Killed Virus

Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin

For Use in Animals Only

Vira Shield 6 + L5HB Indications

For use in healthy cattle, including pregnant cows and heifers, as an aid in the prevention of disease caused by infectious bovine rhinotracheitis (IBR), bovine virus diarrhea (BVD Type 1 and BVD Type 2), parainfluenza Type 3 (PI3), and bovine respiratory syncytial (BRSV) viruses and Leptospira canicola, grippotyphosa, hardjo-bovis, icterohaemorrhagiae, and pomona. For use in calves vaccinated at four weeks of age, or older, as an aid in the prevention of hardjo-bovis kidney colonization, and as an aid in preventing urinary shedding and reproductive tract infection for 12 months. Produced from non-cytopathic (BVD Type 1 and BVD Type 2) and cytopathic (BVD Type 1) isolates. Vaccinated animals subsequently exposed to L. borgpetersenii serovar hardjo (type hardjo-bovis) have been shown to clear renal infections within 8 weeks of exposure.

ADJUVANT: Xtend® SP.

Directions For Use

Shake well before using. Administer 5 mL subcutaneously. In accordance with Beef Quality Assurance guidelines, this product should be administered subcutaneously (under the skin) in the neck. Revaccinate in 4-5 weeks. Vaccinate dairy cows at dry-off. Revaccinate annually or as recommended by your veterinarian.

Precautions

Store out of direct sunlight at 2°-7°C (35°-45°F). DO NOT FREEZE. Use entire contents when first opened. Do not vaccinate within 60 days prior to slaughter. Transient swelling may occur at the site of injection. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains amphotericin B, gentamicin, and thimerosal as preservatives.

U.S. Vet. License No. 303

Novartis Animal Health US, Inc.

©2012 Novartis; Registered trademarks of Novartis AG, used under license.

Novartis Animal Health Canada Inc., Mississauga, Ontario, Canada L5N 1V9

1-800-387-6325

10 Doses

50 mL

370CA-05

50 Doses

250 mL

 

NAC No.: 1231099.1

ELANCO CANADA LIMITED
Distributed by ELANCO, Division Eli Lilly Canada Inc. & ELANCO CANADA LIMITED (successor to Novartis Animal Health Canada Inc.)
RESEARCH PARK CENTRE, 150 RESEARCH LANE, SUITE 120, GUELPH, ON, N1G 4T2
Telephone:   519-821-0277
Order Desk:   800-773-7603
Fax:   519-821-7831
Elanco Canada Limited Customer Service Telephone:   800-387-6325
Elanco Canada Limited Customer Service Fax:   800-827-5782
Website:   www.Elanco.ca
Every effort has been made to ensure the accuracy of the Vira Shield 6 + L5HB information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2016 North American Compendiums. Updated: 2016-08-21

Hide